Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Ganymede logo — Modern cloud platform to capture, automate, and analyze lab...

Ganymede

Modern cloud platform to capture, automate, and analyze lab data.

Founded 2022 United States Jersey City, United States 47 employees Series A Total: $15.65M Biopharma, Enterprise Software +1

General Information

Company Name Ganymede
Founded Year 2022
Location United States Jersey City, United States
Employees 47
Industries Biopharma, Enterprise Software, Life Sciences
Funding Stage Series A
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Usage Based, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Ganymede. To contact Ganymede, visit ganymede.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Ganymede compare?

A PDF of Ganymede and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Ganymede soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Ganymede

Ganymede, a subsidiary of Apprentice.io, is revolutionizing the biopharma and life sciences industries with its Modern cloud platform to capture, automate, and analyze lab data. Established in 2022 and headquartered in the United States, this company offers a unique proposition through its proprietary Lab-as-Code™ technology.

The platform connects lab instruments, ELNs, LIMS, and apps into a single modular cloud platform, enabling automatic data capture and standardized workflows. This innovation accelerates time-to-insight for companies ranging from early-stage biotechs to large pharmaceutical manufacturers. Scientists benefit from automated analysis, eliminating manual data transfer, and establishing a traceable data foundation ready for AI and analytics.

Ganymede received a substantial $12.75M Series A investment on 09 August 2022 from Caffeinated Capital, showcasing strong confidence in its potential to transform lab operations in life sciences.

Business keywords: cloud data platform, life sciences, Lab-as-Code, lab operations automation, ELN integration, LIMS integration, biotech software engineering, data capture automation, workflow standardization, real-time data dashboards, AI-ready data foundation, low-code platform, software and hardware integration, pipelines construction, traceable data foundation

Services & Products

Automate upstream and downstream processing
Standardize and unify lab data
Accelerate chromatography analysis
Lab data infrastructure tools
AI-driven experiment data capture

Target Customers

Bioprocess Engineers Lab Scientists IT and Developers in Scientific Labs R&D Leaders in Biotechnology Companies focusing on biologics and synthetic biology

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $12.75M 1
Caffeinated Capital
Caffeinated Capital
09 Aug 2022
Pre Seed Round $2.90M 3
BoxGroup Caffeinated Capital SciFi VC
BoxGroup, Caffeinated Capital +1
15 Apr 2022

Latest News

View All
Ganymede and Callisto: frozen fates with divergent origins — Techno-science.net
Ganymede and Callisto: frozen fates with divergent origins
Techno-science.net Jun 29, 2025

Ganymede Alternatives & Competitors

Ganymede vs
Discover Echo Inc.
Discover Echo Inc. United States

Experience Precision in Biological Research with Advanced Automated Microscopy for Accurate Imaging...

Series A
68 employees
Biopharma, Biotechnology
Compare Ganymede vs Discover Echo Inc.

FAQ About Ganymede

Modern cloud platform to capture, automate, and analyze lab data.
Ganymede was founded in 2022.
Ganymede is headquartered in Jersey City, United States.
Ganymede operates in Biopharma, Enterprise Software and Life Sciences. Its work centres on cloud data platform, life sciences, Lab-as-Code and lab operations automation. Its customers include Bioprocess Engineers, Lab Scientists and IT and Developers in Scientific Labs.
Ganymede has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Usage Based and Service Fee.
Ganymede has approximately 47 employees.
Ganymede has completed 2 funding rounds, raising a total of $15.65M. The latest funding stage is Series A.
Ganymede offers: Automate upstream and downstream processing, Standardize and unify lab data, Accelerate chromatography analysis, Lab data infrastructure tools, AI-driven experiment data capture.
Top alternatives and competitors to Ganymede include Discover Echo Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ganymede and Discover Echo Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ganymede, https://bouncewatch.com/company/ganymede, updated 15 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes